Commercializing cell and gene therapies
Cell and gene therapies promise to transform patient outcomes by unlocking cures for diseases with high-unmet need. Yet, their complex nature presents therapy owners with unprecedented challenges across logistics, commercialization, market access, and reimbursement that threaten to derail a product’s success. Therapy owners must design forward-looking, patient-centric plans to navigate the journey from preclinical development to commercial manufacturing and commercialization success.
Download the white paper